{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:05:42Z","timestamp":1790219142080,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T00:00:00Z","timestamp":1537401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T00:00:00Z","timestamp":1537401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Glycine N-methyltransferase (GNMT) is the most abundant methyltransferase in the liver and a master regulator of the transmethylation flux. GNMT downregulation leads to loss of liver function progressing to fibrosis, cirrhosis, and hepatocellular carcinoma. Moreover, GNMT deficiency aggravates cholestasis-induced fibrogenesis. To date, little is known about the mechanisms underlying downregulation of GNMT levels in hepatic fibrosis and cirrhosis. On this basis, microRNAs are epigenetic regulatory elements that play important roles in liver pathology. In this work, we aim to study the regulation of <jats:italic>GNMT<\/jats:italic> by microRNAs during liver fibrosis and cirrhosis. Luciferase assay on the 3\u02b9UTR-<jats:italic>Gnmt<\/jats:italic> was used to confirm in silico analysis showing that <jats:italic>GNMT<\/jats:italic> is potentially targeted by the microRNA miR-873-5p. Correlation between <jats:italic>GNMT<\/jats:italic> and miR-873-5p in human cholestasis and cirrhosis together with miR-873-5p inhibition in vivo in different mouse models of liver cholestasis and fibrosis [bile duct ligation and <jats:italic>Mdr2 (Abcb4)<\/jats:italic><jats:sup><jats:italic>-\/-<\/jats:italic><\/jats:sup> mouse] were then assessed. The analysis of liver tissue from cirrhotic and cholestatic patients, as well as from the animal models, showed that miR-873-5p inversely correlated with the expression of <jats:italic>GNMT<\/jats:italic>. Importantly, high circulating miR-873-5p was also detected in cholestastic and cirrhotic patients. Preclinical studies with anti-miR-873-5p treatment in bile duct ligation and <jats:italic>Mdr2<\/jats:italic><jats:sup>-\/-<\/jats:sup> mice recovered GNMT levels in association with ameliorated inflammation and fibrosis mainly by counteracting hepatocyte apoptosis and cholangiocyte proliferation. In conclusion, miR-873-5p emerges as a novel marker for liver fibrosis, cholestasis, and cirrhosis and therapeutic approaches based on anti-miR-873-5p may be effective treatments for liver fibrosis and cholestatic liver disease.<\/jats:p>","DOI":"10.1038\/s41419-018-1014-y","type":"journal-article","created":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T13:34:43Z","timestamp":1537450483000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis"],"prefix":"10.1038","volume":"9","author":[{"given":"David","family":"Fern\u00e1ndez-Ramos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Fern\u00e1ndez-Tussy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Lopitz-Otsoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Guti\u00e9rrez-de-Juan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00e1s","family":"Navasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Barbier-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imanol","family":"Zubiete-Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Sim\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agust\u00edn F.","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ander","family":"Arbelaiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8271-612X","authenticated-orcid":false,"given":"Ana M.","family":"Aransay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Lav\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naiara","family":"Beraza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda J.","family":"Perugorria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus M.","family":"Banales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6388-7022","authenticated-orcid":false,"given":"Erica","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario F.","family":"Fraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2061-7182","authenticated-orcid":false,"given":"Juan","family":"Anguita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matias A.","family":"Avila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Berasain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Iruzibieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly C.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Varela-Rey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Mato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa C.","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda L.","family":"Mart\u00ednez-Chantar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,20]]},"reference":[{"key":"1014_CR1","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/S0168-8278(00)80122-1","volume":"33","author":"MA Avila","year":"2000","unstructured":"Avila, M. A. et al. Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma. J. Hepatol. 33, 907\u2013914 (2000).","journal-title":"J. Hepatol."},{"key":"1014_CR2","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1111\/j.1440-1746.2008.05488.x","volume":"23","author":"YC Huang","year":"2008","unstructured":"Huang, Y. -C. et al. Glycine N-methyltransferase is a favorable prognostic marker for human cholangiocarcinoma. J. Gastroenterol. Hepatol. 23, 1384\u20131389 (2008).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"1014_CR3","doi-asserted-by":"publisher","first-page":"744","DOI":"10.2119\/molmed.2011.00396","volume":"18","author":"CY Chen","year":"2012","unstructured":"Chen, C. -Y. et al. Deficiency of glycine N-methyltransferase aggravates atherosclerosis in apolipoprotein E\u2013null mice. Mol. Med. 18, 744\u2013752 (2012).","journal-title":"Mol. Med."},{"key":"1014_CR4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0021-9258(19)44446-3","volume":"248","author":"JE Heady","year":"1973","unstructured":"Heady, J. E. & Kerr, S. J. Purification and characterization of glycine N-methyltransferase. J. Biol. Chem. 248, 69\u201372 (1973).","journal-title":"J. Biol. Chem."},{"key":"1014_CR5","doi-asserted-by":"publisher","first-page":"27856","DOI":"10.1074\/jbc.M203911200","volume":"277","author":"C Farrar","year":"2002","unstructured":"Farrar, C. & Clarke, S. Altered levels of S-adenosylmethionine and S-adenosylhomocysteine in the brains ofl-isoaspartyl (d-Aspartyl)O-methyltransferase-deficient mice. J. Biol. Chem. 277, 27856\u201327863 (2002).","journal-title":"J. Biol. Chem."},{"key":"1014_CR6","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/(SICI)1097-0215(19980302)75:5<787::AID-IJC20>3.0.CO;2-2","volume":"75","author":"YM Chen","year":"1998","unstructured":"Chen, Y. M. et al. Characterization of glycine-N-methyltransferase-gene expression in human hepatocellular carcinoma. Int. J. Cancer J. Int. Cancer 75, 787\u2013793 (1998).","journal-title":"Int. J. Cancer J. Int. Cancer"},{"key":"1014_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/labinvest.2014.151","volume":"95","author":"S Fern\u00e1ndez-\u00c1lvarez","year":"2015","unstructured":"Fern\u00e1ndez-\u00c1lvarez, S. et al. TRAIL-producing NK cells contribute to liver injury and related fibrogenesis in the context of GNMT deficiency. Lab. Investig. J. Tech. Methods Pathol. 95, 223\u2013236 (2015).","journal-title":"Lab. Investig. J. Tech. Methods Pathol."},{"key":"1014_CR8","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1002\/hep.22159","volume":"47","author":"ML Mart\u00ednez-Chantar","year":"2008","unstructured":"Mart\u00ednez-Chantar, M. L. et al. Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice. Hepatol. Baltim. Md. 47, 1191\u20131199 (2008).","journal-title":"Hepatol. Baltim. Md."},{"key":"1014_CR9","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s00109-013-1010-8","volume":"91","author":"C Huidobro","year":"2013","unstructured":"Huidobro, C. et al. A DNA methylation signature associated with the epigenetic repression of glycine N-methyltransferase in human hepatocellular carcinoma. J. Mol. Med. Berl. Ger. 91, 939\u2013950 (2013).","journal-title":"J. Mol. Med. Berl. Ger."},{"key":"1014_CR10","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.sbi.2005.05.006","volume":"15","author":"W Filipowicz","year":"2005","unstructured":"Filipowicz, W., Jaskiewicz, L., Kolb, F. A. & Pillai, R. S. Post-transcriptional gene silencing by siRNAs and miRNAs. Curr. Opin. Struct. Biol. 15, 331\u2013341 (2005).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"1014_CR11","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/435745a","volume":"435","author":"PS Meltzer","year":"2005","unstructured":"Meltzer, P. S. Cancer genomics: small RNAs with big impacts. Nature 435, 745\u2013746 (2005).","journal-title":"Nature"},{"key":"1014_CR12","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1056\/NEJMra072367","volume":"358","author":"CM Croce","year":"2008","unstructured":"Croce, C. M. Oncogenes and cancer. N. Engl. J. Med. 358, 502\u2013511 (2008).","journal-title":"N. Engl. J. Med."},{"key":"1014_CR13","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nrgastro.2013.183","volume":"10","author":"GA Michelotti","year":"2013","unstructured":"Michelotti, G. A., Machado, M. V. & Diehl, A. M. NAFLD, NASH and liver cancer. Nat. Rev. Gastroenterol. Hepatol. 10, 656\u2013665 (2013).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1014_CR14","doi-asserted-by":"publisher","first-page":"G289","DOI":"10.1152\/ajpcell.1997.272.1.C289","volume":"272","author":"G Alpini","year":"1997","unstructured":"Alpini, G. et al. Molecular and functional heterogeneity of cholangiocytes from rat liver after bile duct ligation. Am. J. Physiol. 272, G289\u2013G297 (1997).","journal-title":"Am. J. Physiol."},{"key":"1014_CR15","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.jhep.2005.06.025","volume":"43","author":"Y Popov","year":"2005","unstructured":"Popov, Y., Patsenker, E., Fickert, P., Trauner, M. & Schuppan, D. Mdr2 (Abcb4)-\/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes. J. Hepatol. 43, 1045\u20131054 (2005).","journal-title":"J. Hepatol."},{"key":"1014_CR16","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/hep.28933","volume":"65","author":"I Zubiete-Franco","year":"2017","unstructured":"Zubiete-Franco, I. et al. Deregulated neddylation in liver fibrosis. Hepatol. Baltim. Md. 65, 694\u2013709 (2017).","journal-title":"Hepatol. Baltim. Md."},{"key":"1014_CR17","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.22136","volume":"47","author":"A Kahraman","year":"2008","unstructured":"Kahraman, A. et al. TRAIL mediates liver injury by the innate immune system in the bile duct\u2013ligated mouse. Hepatology 47, 1317\u20131330 (2008).","journal-title":"Hepatology"},{"key":"1014_CR18","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1586\/17474124.1.1.173","volume":"1","author":"B Gao","year":"2007","unstructured":"Gao, B., Radaeva, S. & Jeong, W. -I. Activation of natural killer cells inhibits liver fibrosis: a novel strategy to treat liver fibrosis. Expert Rev. Gastroenterol. Hepatol. 1, 173\u2013180 (2007).","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"1014_CR19","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/hep.25694","volume":"56","author":"L Gomez-Santos","year":"2012","unstructured":"Gomez-Santos, L. et al. Inhibition of NK cells protects the liver against acute injury in the absence of GNMT. Hepatol. Baltim. Md. 56, 747\u2013759 (2012).","journal-title":"Hepatol. Baltim. Md."},{"key":"1014_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3823","volume":"4","author":"I Mederacke","year":"2013","unstructured":"Mederacke, I. et al. Fate-tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its etiology. Nat. Commun. 4, 2823 (2013).","journal-title":"Nat. Commun."},{"key":"1014_CR21","doi-asserted-by":"publisher","first-page":"e0173914","DOI":"10.1371\/journal.pone.0173914","volume":"12","author":"V Guti\u00e9rrez-de-Juan","year":"2017","unstructured":"Guti\u00e9rrez-de-Juan, V. et al. A morphological method for ammonia detection in liver. PLoS ONE 12, e0173914 (2017).","journal-title":"PLoS ONE"},{"key":"1014_CR22","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1002\/hep.27131","volume":"60","author":"DA Mann","year":"2014","unstructured":"Mann, D. A. Epigenetics in liver disease. Hepatol. Baltim. Md. 60, 1418\u20131425 (2014).","journal-title":"Hepatol. Baltim. Md."},{"issue":"1","key":"1014_CR23","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3390\/ijms18010192","volume":"18","author":"Ya-Ling Yang","year":"2017","unstructured":"Yang, Y.-L., Wang, F.-S., Li, S.-C., Tiao, M.-M. & Huang, Y.-H. MicroRNA-29a Alleviates Bile Duct Ligation Exacerbation of Hepatic Fibrosis in Mice through Epigenetic Control of Methyltransferases. Int. J. Mol. Sci. 18, (2017).","journal-title":"International Journal of Molecular Sciences"},{"key":"1014_CR24","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.jhep.2015.11.024","volume":"64","author":"A Page","year":"2016","unstructured":"Page, A. et al. Hepatic stellate cell transdifferentiation involves genome-wide remodeling of the DNA methylation landscape. J. Hepatol. 64, 661\u2013673 (2016).","journal-title":"J. Hepatol."},{"key":"1014_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jcmgh.2017.04.007","volume":"4","author":"E Moran-Salvador","year":"2017","unstructured":"Moran-Salvador, E. & Mann, J. Epigenetics and liver fibrosis. Cell. Mol. Gastroenterol. Hepatol. 4, 125\u2013134 (2017).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"1014_CR26","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1136\/gutjnl-2015-311292","volume":"65","author":"T Hardy","year":"2016","unstructured":"Hardy, T. & Mann, D. A. Epigenetics in liver disease: from biology to therapeutics. Gut 65, 1895\u20131905 (2016).","journal-title":"Gut"},{"key":"1014_CR27","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0092-8674(00)81656-6","volume":"99","author":"M Okano","year":"1999","unstructured":"Okano, M., Bell, D. W., Haber, D. A. & Li, E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99, 247\u2013257 (1999).","journal-title":"Cell"},{"key":"1014_CR28","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1172\/JCI31457","volume":"117","author":"DF Calvisi","year":"2007","unstructured":"Calvisi, D. F. et al. Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma. J. Clin. Invest. 117, 2713\u20132722 (2007).","journal-title":"J. Clin. Invest."},{"key":"1014_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-016-2814-z","volume":"17","author":"HB Schi\u00f6th","year":"2016","unstructured":"Schi\u00f6th, H. B. et al. A targeted analysis reveals relevant shifts in the methylation and transcription of genes responsible for bile acid homeostasis and drug metabolism in non-alcoholic fatty liver disease. BMC Genom. 17, 462 (2016).","journal-title":"BMC Genom."},{"key":"1014_CR30","first-page":"881","volume":"51","author":"C Braconi","year":"2010","unstructured":"Braconi, C., Huang, N. & Patel, T. MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes. Hepatology 51, 881\u2013890 (2010).","journal-title":"Hepatology"},{"key":"1014_CR31","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jhep.2017.02.017","volume":"67","author":"M Merino-Azpitarte","year":"2017","unstructured":"Merino-Azpitarte, M. et al. SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma. J. Hepatol. 67, 72\u201383 (2017).","journal-title":"J. Hepatol."},{"key":"1014_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.taap.2012.06.022","volume":"264","author":"EB Bian","year":"2012","unstructured":"Bian, E. -B. et al. DNMT1-mediated PTEN hypermethylation confers hepatic stellate cell activation and liver fibrogenesis in rats. Toxicol. Appl. Pharmacol. 264, 13\u201322 (2012).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"1014_CR33","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/hep.25754","volume":"56","author":"MJ Perugorria","year":"2012","unstructured":"Perugorria, M. J. et al. Histone methyltransferase ASH1 orchestrates fibrogenic gene transcription during myofibroblast transdifferentiation. Hepatol. Baltim. Md. 56, 1129\u20131139 (2012).","journal-title":"Hepatol. Baltim. Md."},{"key":"1014_CR34","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/hep.26661","volume":"59","author":"CA Moylan","year":"2014","unstructured":"Moylan, C. A. et al. Hepatic gene expression profiles differentiate pre-symptomatic patients with mild versus severe nonalcoholic fatty liver disease. Hepatol. Baltim. Md. 59, 471\u2013482 (2014).","journal-title":"Hepatol. Baltim. Md."},{"key":"1014_CR35","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1053\/j.gastro.2013.07.047","volume":"145","author":"SK Murphy","year":"2013","unstructured":"Murphy, S. K. et al. Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease. Gastroenterology 145, 1076\u20131087 (2013).","journal-title":"Gastroenterology"},{"key":"1014_CR36","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller, R. & Brenner, D. A. Liver fibrosis. J. Clin. Invest. 115, 209\u2013218 (2005).","journal-title":"J. Clin. Invest."},{"key":"1014_CR37","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jhep.2009.03.024","volume":"51","author":"JX Jiang","year":"2009","unstructured":"Jiang, J. X., Mikami, K., Venugopal, S., Li, Y. & T\u00f6r\u00f6k, N. J. Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK\/STAT and Akt\/NF-\u03baB-dependent pathways. J. Hepatol. 51, 139\u2013148 (2009).","journal-title":"J. Hepatol."},{"key":"1014_CR38","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1136\/gut.2009.186528","volume":"59","author":"A Baghdasaryan","year":"2010","unstructured":"Baghdasaryan, A. et al. Curcumin improves sclerosing cholangitis in Mdr2\u2212\/\u2212 mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation. Gut 59, 521\u2013530 (2010).","journal-title":"Gut"},{"key":"1014_CR39","doi-asserted-by":"publisher","first-page":"54348","DOI":"10.1074\/jbc.M410021200","volume":"279","author":"M Ananthanarayanan","year":"2004","unstructured":"Ananthanarayanan, M., Li, S., Balasubramaniyan, N., Suchy, F. J. & Walsh, M. J. Ligand-dependent activation of the farnesoid X-receptor directs arginine methylation of histone H3 by CARM1. J. Biol. Chem. 279, 54348\u201354357 (2004).","journal-title":"J. Biol. Chem."},{"key":"1014_CR40","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/hep.28599","volume":"64","author":"O Waisbourd-Zinman","year":"2016","unstructured":"Waisbourd-Zinman, O. et al. The toxin biliatresone causes mouse extrahepatic cholangiocyte damage and fibrosis through decreased glutathione and SOX17. Hepatol. Baltim. Md. 64, 880\u2013893 (2016).","journal-title":"Hepatol. Baltim. Md."},{"key":"1014_CR41","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ymthe.2016.10.004","volume":"25","author":"M Zeybel","year":"2017","unstructured":"Zeybel, M. et al. A proof-of-concept for epigenetic therapy of tissue fibrosis: inhibition of liver fibrosis progression by 3-deazaneplanocin A. Mol. Ther. J. Am. Soc. Gene Ther. 25, 218\u2013231 (2017).","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"1014_CR42","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1053\/j.gastro.2009.10.002","volume":"138","author":"J Mann","year":"2010","unstructured":"Mann, J. et al. MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis. Gastroenterology 138, 705\u2013714 (2010). 714\u20134.","journal-title":"Gastroenterology"},{"key":"1014_CR43","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s11248-006-0008-1","volume":"15","author":"Z Luka","year":"2006","unstructured":"Luka, Z., Capdevila, A., Mato, J. M. & Wagner, C. A Glycine N-methyltransferase knockout mouse model for humans with deficiency of this enzyme. Transgenic. Res. 15, 393\u2013397 (2006).","journal-title":"Transgenic. Res."},{"key":"1014_CR44","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1002\/hep.24795","volume":"55","author":"N Embade","year":"2012","unstructured":"Embade, N. et al. Murine double minute 2 regulates Hu antigen R stability in human liver and colon cancer through NEDDylation. Hepatol. Baltim. Md. 55, 1237\u20131248 (2012).","journal-title":"Hepatol. Baltim. Md."},{"key":"1014_CR45","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1053\/j.gastro.2012.05.050","volume":"143","author":"N Mart\u00ednez-L\u00f3pez","year":"2012","unstructured":"Mart\u00ednez-L\u00f3pez, N. et al. Hepatoma cells from mice deficient in glycine N-methyltransferase have increased RAS signaling and activation of liver kinase B1. Gastroenterology 143, 787\u2013798.e13 (2012).","journal-title":"Gastroenterology"},{"key":"1014_CR46","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ab.2011.01.026","volume":"412","author":"T Le","year":"2011","unstructured":"Le, T., Kim, K. -P., Fan, G. & Faull, K. F. A sensitive mass spectrometry method for simultaneous quantification of DNA methylation and hydroxymethylation levels in biological samples. Anal. Biochem. 412, 203\u2013209 (2011).","journal-title":"Anal. Biochem."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1014-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1014-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1014-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:14:47Z","timestamp":1671538487000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1014-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,20]]},"references-count":46,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,10]]}},"alternative-id":["1014"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-1014-y","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,20]]},"assertion":[{"value":"1 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.L. Mart\u00ednez-Chantar: Consultant\/Advisory Board for Mitotherapeutix LLC. J. Mato: Consultant\/Advisory Board for Abbott and Galmed, owns stocks for OWL. The other authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"958"}}